A novel mRNA cancer vaccine helps reduce the chances of melanoma patients tumors returning
WASHINGTON (AP) — A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck. The vaccine was custom-brewed for each patient to match their tumor. Adding it to a standard post-surgery treatment reduced by 42% the risk of melanoma returning two years after surgery, according to the most advanced study to date of this new strategy for fighting cancer...
Read MoreThu, 22 Oct 2026
- A novel mRNA cancer vaccine helps reduce the chances of melanoma patients tumors returning
- New study traces van Goghs famed Starry Night to an actual night sky from 1889
- Childrens singer Raffi on his 50-year career, screen time and Ms. Rachel
- Dusky shark that became a tourist draw while trapped in a South Korean canal finally swims free
Wed, 21 Oct 2026
- Whether stringing or looping, tobacco is the tie that binds many North Carolina farm families
- A Treasury of Ice goes on show, revealing relics as Swiss glaciers rapidly melt
Tue, 20 Oct 2026
- The Simpsons resurrects Apu after nearly a decade of silence
Mon, 19 Oct 2026
- A historical society with pilots help bought Neil Armstrongs boyhood home and will offer tours
- Bringing more beavers to watersheds is a powerful drought-fighting tool, experts say
- Barcelona grandmas dish out cooking wisdom. And find nourishment themselves
----------
Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Copyright © 1996 - 2026 CoreComm Internet Services, Inc. All Rights Reserved. | View our Privacy Policy
CoreComm is not responsible for content on external sites. Please review the privacy and security policies of each vendor before making online purchases or providing personal information. Forecast Information Provided by AccuWeather.